Senolytic Peptide FOXO4-DRI Clears Aging Cells from Human Cartilage Cells

Cellular senescence, where cells stop dividing and accumulate, contributes significantly to age-related conditions like osteoarthritis by releasing pro-inflammatory factors and damaging surrounding tissues. Chondrocytes, the cells responsible for maintaining cartilage, are particularly vulnerable to senescence, leading to cartilage degradation and joint pain. This study addresses the critical need for targeted strategies to selectively remove senescent cells from human chondrocytes to preserve cartilage health and function.

The study unequivocally demonstrated that FOXO4-DRI effectively and selectively eliminated senescent cells from the chondrocyte cultures. At an optimal concentration of 5 µM, FOXO4-DRI led to a highly significant 60% reduction in SA-β-gal activity (a widely recognized biomarker for senescent cells) compared to vehicle-treated controls (p<0.001), indicating potent senolytic activity. The most critical finding was that FOXO4-DRI specifically induced apoptosis (programmed cell death) in senescent chondrocytes without causing any detectable harm to healthy, non-senescent cells, maintaining their viability at over 95% across all tested concentrations. Furthermore, the expression of key senescence-associated genes, p16INK4a and p21WAF1/Cip1, which are crucial regulators of cell cycle arrest, was markedly decreased by 2.5-fold and 3-fold, respectively, in the treated cultures. This selective removal of detrimental senescent cells also resulted in a significant improvement in the proliferative capacity of the remaining healthy chondrocytes, showing a 43% increase in cell division rates compared to untreated senescent cultures, suggesting a rejuvenation effect.